An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study

Our exosome-based transcriptomic signature that combines cell-free and exosomal microRNAs has the potential to identify patients with pancreatic ductal adenocarcinoma with high diagnostic accuracy, and offers an important noninvasive assay for early detection of this fatal malignancy.